Loss of the SMRT/NCoR2 corepressor correlates with JAG2 overexpression in multiple myeloma.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Cancer Research

• Publication date

  2009-05-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/0008-5472.CAN-08-3467PMID 19417136
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nuclear receptor mediated gene regulation through chromatin remodeling and histone modifications.

  2006cited by this paper
• The corepressors silencing mediator of retinoid and thyroid hormone receptor and nuclear receptor corepressor are involved in agonist- and antagonist-regulated transcription by androgen receptor.

  2006cited by this paper
• Alteration of SMRT tumor suppressor function in transformed non-Hodgkin lymphomas.

  2005cited by this paper
• Activation of human cancer/testis antigen gene, XAGE‐1, in tumor cells is correlated with CpG island hypomethylation

  2005cited by this paper
• Involvement of Notch-1 signaling in bone marrow stroma-mediated de novo drug resistance of myeloma and other malignant lymphoid cell lines.

  2004cited by this paper
• TAT-mediated protein transduction into human corneal epithelial cells: p15(INK4b) inhibits cell proliferation and stimulates cell migration.

  2004cited by this paper
• Overexpression of the NOTCH ligand JAG2 in malignant plasma cells from multiple myeloma patients and cell lines.

  2004influential reference
• Histone acetylation and deacetylation in yeast

  2003cited by this paper
• An overview of the Notch signalling pathway.

  2003cited by this paper
• The N-CoR-HDAC3 nuclear receptor corepressor complex inhibits the JNK pathway through the integral subunit GPS2.

  2002cited by this paper
• Assembly of the SMRT-histone deacetylase 3 repression complex requires the TCP-1 ring complex.

  2002cited by this paper
• Comparison of gene expression profiling between malignant and normal plasma cells with oligonucleotide arrays

  2002cited by this paper
• The SMRT and N-CoR Corepressors Are Activating Cofactors for Histone Deacetylase 3

  2001cited by this paper
• Identifying intercellular signaling genes expressed in malignant plasma cells by using complementary DNA arrays.

  2001cited by this paper
• Characterization, chromosomal localization, and the complete 30-kb DNA sequence of the human Jagged2 (JAG2) gene.

  2000cited by this paper
• Interaction of the nuclear protein CBF1 with the kappaB site of the IL- 6 gene promoter

  1999cited by this paper
• Notch signaling: cell fate control and signal integration in development.

  1999cited by this paper
• Interaction of the nuclear protein CBF 1 with the κ B site of the IL-6 gene promoter

  1999influential reference
• Notch Signaling : Cell Fate Control and Signal Integration in Development

  1999cited by this paper
• Crystal structure of the nucleosome core particle at 2.8 Å resolution

  1997cited by this paper
• Nuclear histone acetylases and deacetylases and transcriptional regulation: HATs off to HDACs.

  1997cited by this paper
• Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.

  1996cited by this paper
• Adhesion of multiple myeloma cells to the bone marrow microenvironment: implications for future therapeutic strategies.

  1996cited by this paper
• A Mammalian Histone Deacetylase Related to the Yeast Transcriptional Regulator Rpd3p

  1996cited by this paper
• Transcriptional repression by YY1 is mediated by interaction with a mammalian homolog of the yeast global regulator RPD3.

  1996cited by this paper
• Physical interaction between a novel domain of the receptor Notch and the transcription factor RBP-J kappa/Su(H).

  1995cited by this paper
• A transcriptional co-repressor that interacts with nuclear hormone receptors

  1995cited by this paper
• Mad-Max transcriptional repression is mediated by ternary complex formation with mammalian homologs of yeast repressor Sin3.

  1995cited by this paper
• Physical interaction between a novel domain of the receptor Notch and the transcription factor RBP-Jκ/Su(H)

  1995cited by this paper
• Interleukin-6 in human multiple myeloma.

  1995cited by this paper
• Masking of the CBF1/RBPJ kappa transcriptional repression domain by Epstein-Barr virus EBNA2.

  1995cited by this paper
• Tat-mediated delivery of heterologous proteins into cells.

  1994cited by this paper
• "Benign" monoclonal gammopathy--after 20 to 35 years of follow-up.

  1993cited by this paper
• Interleukin‐6 dependence of advanced malignant plasma cell dyscrasias

  1992cited by this paper
• Endocytosis and targeting of exogenous HIV‐1 Tat protein.

  1991cited by this paper
• Cellular uptake of the tat protein from human immunodeficiency virus.

  1988cited by this paper
• Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas

  1988cited by this paper
• R E V I E W a Rt I C L E

  year unknowncited by this paper

• DOT1L Mediates Stem Cell Maintenance and Represents a Therapeutic Vulnerability in Cancer

  2024cites this paper
• Cancer stem cell, chromosomal instability, and cancer immunity

  2024cites this paper
• Epigenetic regulation and therapeutic targets in the tumor microenvironment

  2023cites this paper
• Oxidized ATM governs stemness of breast cancer stem cell through regulating ubiquitylation and acetylation switch.

  2023cites this paper
• Histone modifications in drug-resistant cancers: From a cancer stem cell and immune evasion perspective

  2023cites this paper
• The epigenetics orchestra of Notch signaling: a symphony for cancer therapy.

  2023cites this paper
• Heterozygous Kmt2d loss diminishes enhancers to render medulloblastoma cells vulnerable to combinatory inhibition of lysine demethylation and oxidative phosphorylation

  2023cites this paper
• Exploring the dynamic interplay between cancer stem cells and the tumor microenvironment: implications for novel therapeutic strategies

  2023cites this paper
• The Potential of JAG Ligands as Therapeutic Targets and Predictive Biomarkers in Multiple Myeloma

  2023cites this paper
• Biological relationship between bone and myeloma cells

  2022cites this paper
• Cancer Stem Cells: An Ever-Hiding Foe.

  2022cites this paper
• The metabolic addiction of cancer stem cells

  2022cites this paper
• Notch Signaling and Cross-Talk in Hypoxia: A Candidate Pathway for High-Altitude Adaptation

  2022cites this paper
• Understanding the Role of Plasticity in Glioblastoma

  2021cites this paper
• Current understanding of epigenetics mechanism as a novel target in reducing cancer stem cells resistance

  2021cites this paper
• Aspects of the Tumor Microenvironment Involved in Immune Resistance and Drug Resistance

  2021cites this paper
• Low NCOR2 levels in multiple myeloma patients drive multidrug resistance via MYC upregulation

  2021cites this paper
• Therapies approach based on metabolism of cancer stem cells

  2021cites this paper
• Role and Therapeutic Targeting of SDF-1α/CXCR4 Axis in Multiple Myeloma

  2021cites this paper
• Cancer Stem Cells: Devil or Savior—Looking behind the Scenes of Immunotherapy Failure

  2020cites this paper
• Advances in Therapeutic Targeting of Cancer Stem Cells within the Tumor Microenvironment: An Updated Review

  2020cites this paper
• Jagged Ligands Enhance the Pro-Angiogenic Activity of Multiple Myeloma Cells

  2020cites this paper
• Regenerative Medicine and Stem Cell Biology

  2020cites this paper
• Epigenetics in Stem Cell Biology

  2020cites this paper
• The pan-cancer lncRNA PLANE regulates an alternative splicing program to promote cancer pathogenesis

  2020cites this paper
• Biophysical and Epigenetic Regulation of Cancer Stemness, Invasiveness, and Immune Action

  2020cites this paper
• lncRNA CEBPA-AS1 Overexpression Inhibits Proliferation and Migration and Stimulates Apoptosis of OS Cells via Notch Signaling

  2019cites this paper
• Overexpression of JAG2 is related to poor outcomes in oral squamous cell carcinoma

  2019cites this paper
• Role of The Osteoclast in Cancer

  2019cites this paper
• Loss of GTPase activating protein neurofibromin stimulates paracrine cell communication via macropinocytosis

  2019cites this paper
• Meeting the Challenge of Targeting Cancer Stem Cells

  2019cites this paper
• Multiple myeloma exploits Jagged1 and Jagged2 to promote intrinsic and bone marrow-dependent drug resistance

  2019cites this paper
• HP1γ Promotes Lung Adenocarcinoma by Downregulating the Transcription-Repressive Regulators NCOR2 and ZBTB7A.

  2018cites this paper
• Role of Jagged in multiple myeloma-associated angiogenesis

  2018influential citation
• Cancer signaling pathways with a therapeutic approach: An overview in epigenetic regulations of cancer stem cells.

  2018cites this paper
• The NOTCH Pathway and Its Mutations in Mature B Cell Malignancies

  2018cites this paper
• Identification of small molecules uncoupling the Notch::Jagged interaction through an integrated high-throughput screening

  2017cites this paper
• ChimeRScope: a novel alignment-free algorithm for fusion transcript prediction using paired-end RNA-Seq data

  2017cites this paper
• Epigenetics in cancer stem cells

  2017cites this paper
• Epigenetic strategies to reverse drug resistance in heterogeneous multiple myeloma

  2017cites this paper
• Multiple myeloma-derived Jagged ligands increases autocrine and paracrine interleukin-6 expression in bone marrow niche

  2016influential citation
• Nitric Oxide-cGMP Signaling Stimulates Erythropoiesis through Multiple Lineage-Specific Transcription Factors: Clinical Implications and a Novel Target for Erythropoiesis

  2016cites this paper
• Quantitative proteomic analyses of mammary organoids reveals distinct signatures after exposure to environmental chemicals

  2016cites this paper
• The mechanistic role of epigenetic in multiple myeloma

  2016influential citation
• Copy number variation in archival melanoma biopsies versus benign melanocytic lesions

  2016cites this paper
• ChimeRScope: a novel alignment-free algorithm for fusion gene prediction using paired-end short reads

  2016cites this paper
• Targeting Notch as a Therapeutic Approach for Human Malignancies.

  2016cites this paper
• Distinguishing Melanocytic Nevi from Melanoma by DNA Copy Number Changes: Array-Comparative Genomic Hybridization as a Research Tool

  2015cites this paper
• Regulation of breast cancer stem cell features

  2015cites this paper
• MECHANISMS OF DRUG-ESCAPE AND RELAPSE IN MULTIPLE MYELOMA: INTERPLAY BETWEEN ADAR1 AND NOTCH IN ABERRANT RNA EDITING

  2015cites this paper
• Notch signaling deregulation in multiple myeloma: A rational molecular target

  2015cites this paper
• Multispectral Imaging

  2014cites this paper
• Notch pathway inhibition controls myeloma bone disease in the murine MOPC315.BM model

  2014cites this paper
• Glycosylation Inhibitors Efficiently Inhibit P-Selectin-Mediated Cell Adhesion to Endothelial Cells

  2014influential citation
• Notch signaling drives multiple myeloma induced osteoclastogenesis

  2014influential citation
• RATIONALE FOR A NOTCH-DIRECTED THERAPY TO PREVENT MULTIPLE MYELOMA CROSSTALK WITH THE OSTEOCLASTOGENIC NICHE

  2014cites this paper
• Importance of epigenetic changes in cancer etiology, pathogenesis, clinical profiling, and treatment: what can be learned from hematologic malignancies?

  2013cites this paper
• The Role of Notch Signaling in Multiple Myeloma

  2013cites this paper
• NOTCH PRODUCES A DEREGULATION OF CXCR4/SDF-1A CHEMOKINE SIGNALING IN MULTIPLE MYELOMA CELLS

  2013cites this paper
• Notch-directed microenvironment reprogramming in myeloma: a single path to multiple outcomes

  2013cites this paper
• Role of Notch signalling pathway in cancer and its association with DNA methylation

  2013cites this paper
• Mutations impliquées dans la progression du cancer épithélial de l'ovaire

  2013cites this paper
• Modulation of notch signaling components in presence of epigenetic modulators in breast cancer

  2013cites this paper
• "Genome-wide analysis of miRNA gene methylation in non-small cell lung cancer patients"

  2013cites this paper
• Genetic and Molecular Epidemiology of Multiple Myeloma

  2013cites this paper
• [Epigenetics in cancer stem cells].

  2013cites this paper
• Anti-Notch treatment prevents multiple myeloma cells localization to the bone marrow via the chemokine system CXCR4/SDF-1

  2013cites this paper
• Dll1/Notch activation accelerates multiple myeloma disease development by promoting CD138+ MM-cell proliferation

  2012cites this paper
• Università degli Studi di Milano Scuola di Dottorato in Medicina Molecolare

  2012cites this paper
• Altered corepressor SMRT expression and recruitment to target genes as a mechanism that change the response to androgens in prostate cancer progression.

  2012cites this paper
• Dll1/Notch activation contributes to bortezomib resistance by upregulating CYP1A1 in multiple myeloma.

  2012cites this paper
• Differential copy number aberrations in novel candidate genes associated with progression from in situ to invasive ductal carcinoma of the breast

  2012cites this paper
• Epigenetic alterations involved in cancer stem cell reprogramming

  2012cites this paper
• Combined effects of FLT3 and NF‐κB selective inhibitors on acute myeloid leukemia in vivo

  2012cites this paper
• Notch-ing from T-cell to B-cell lymphoid malignancies.

  2011cites this paper
• Immunosuppressive Microenvironment Induces a Prosurvival and CD28 Expressed on Malignant Plasma Cells

  2011cites this paper
• CD28 Expressed on Malignant Plasma Cells Induces a Prosurvival and Immunosuppressive Microenvironment

  2011cites this paper
• Effect of RNAi-induced down regulation of nuclear factor kappa-B p65 on acute monocytic leukemia THP-1 cells in vitro and vivo

  2011cites this paper
• Rôle du système IGF-1/insuline dans le Myélome Multiple

  2009cites this paper